Table 1– Demographic data of the patients

Patient	Sex	Age yrs	Diagnosis	Smoker	FEV₁ L (% pred)		FVC L (% pred)
					L	% pred	L	% pred
1	Male	49	Emphysema	NA	N/A	N/A	N/A	N/A
2	Female	64	Emphysema	NA	N/A	N/A	N/A	N/A
3	Male	62	Mass	Smoker		88		96
4	Male	69	Nonsmall cell carcinoma	Ex-smoker	N/A	N/A	N/A	N/A
5	Male	26	Bronchiolitis obliterans	NA	N/A	N/A	N/A	N/A
6	Male	76	Small cell carcinoma, COPD	Ex-smoker	1.4		1.85
7	Female	59	NSCLC	Ex-smoker	2.93	82	3.43
8	Female	66	Carcinoma	Ex-smoker	N/A	N/A	N/A	N/A
9	Male	65	NSCLC	Smoker	3.11	76	3.98	3.98
10	Male	41	Emphysema	NA	N/A	N/A	N/A	N/A
11	Male	59	Emphysema	NA	N/A	N/A	N/A	N/A
12	Male	66	NSCLC	Smoker	3.4	72	4.8
13	Male	70	NSCLC	NA	N/A	N/A	N/A	N/A
14	Female	45	Donor	NA	N/A	N/A	N/A	N/A
15	Male	64	Carcinoma	Ex-smoker	3.2		3.9
16	Male	70	Carcinoma	Ex-smoker	2.14		3.84
17	Female	51	NSCLC	smoker	3.11	81	3.46
18	Male	62	NSCLC	Ex-smoker	1.98	70	2.37
19	Male	67	COPD	Ex-smoker	0.93	78	1.29
20	Female	47	NSCLC	Ex-smoker	2.75	65	2.96

None of the patients had received any therapy before lung tissue sampling. FEV₁: forced expiratory volume in 1 s; % pred: % predicted; FVC: forced vital capacity; COPD: chronic obstructive pulmonary disease; NSCLC: nonsmall-cell lung carcinoma; N/A: not available.